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ED according to institutional protocol. Triage level assignment for each ED visit was com- 
pared relative to the diagnostic test done on the previous visit. Only patients who had CAD 
excluded across all visits were considered in this analysis 
RESULTS: Of the 19,875 ED visits for CP, 6,653 (34% of all such visits) were by pts with at 
least 2 visits, including 5,977 (90%) which met the critaria for recidivism. These were aftdb- 
utable to 1,385 pts (9% of unique Lots), 892 with CAD and 493 with no evidence of CAD. 
There was a mean of 4,7 visits/pt for those with and 3.6 visits/pt for those without CAD. 
Recidivist pts without CAD were less likely than those with CAD to have HTN (60% vs 78%), 
diabetes (25% vs 39%), or dysiipidemia (29% vs 68%). For pts without CAD, those who had 
a nsgafive catheterization compared to those with a negative stress-imaging study or no 
diagnostic test performed on any given visit were less likely to be risk stratified at a higher 
level on the subsequent visit; 12% cath, vs 28% stress or 25% neither. These proportions 
were similar when comparing visit-2 to visit-1 or visit-3 to visit-2. Risk level was rarely 
changed at any presenation beyond visit-3. 
CONCLUSIONS: 10% of CP pts account for approximately 1/3 of all ED CP visits. This is 
frequently associated with risk stratification to a higher level on subsequent visits. Negative 
catheterization appears to have a greater influence on subsequent decision making in non- 
CAD pts than negative stress-imaging or having no diagnostic test performed. 
1143-165 Low Cost Tele-Echocardiography in an Urban/Suburban 
Environment 
Aoarna Kulkarni, M. Victoria Tantengco, Michael Pettersen, Tajinder P. Singh, Richard 
Humes, Children's Hospital of Michigan, Detroit, Michigan. 
Background: The utility of tele-echocardiography (TEL) is obvious as distances increase 
and access to specialty care decreases, particularly in rural areas. Yet, TEL comes at a 
cost of equipment and services. 
Objsctive: To compare the time and cost effectiveness of low-cost real time (384 Kbps, 
ISDN) TEL with on-site(ONS) echocardiography in an urban/suburban environment where 
travel distances are not great. 
Methods: "lJme activity data were collected over a period of 5 months from cardiologists at 
Children's Hospital of Michigen(CHM), traveling from CHM to other hospitals to review ech- 
oes ONS. Recordings Included travel time, time spent in the facility to review ONS and the 
total miles in travel. Similar measurements were obtained from cardiologists when they 
were reviewing echoes via TEL. Costs included telemedicine equipment ($8000), physician 
time ($60/hr), telephone line charges ($1200/site/yr) and mileage charges ($0.325/mi). 
Results: 138 Echoes were interpreted over 5 months of ONS echocardiography during the 
time study. 41.74 (+/-29,1)minutes were spent per echo, in addition to 22.5 (+/-10.7) min- 
utes of travel time with an average commute of 12.5 (+/-6.5) miles per echo. Thirty-six ech- 
oes were interpreted via TEL over a period of 3 weeks. Each echo required 14.77 (+/-4.3) 
rain. The physician time spent for ONS vs. TEL was significantly longer (p<0.000t). The 
cost of TEL equipment was compared to the cost of travelling for every ECHO performed. 
ONS interpretation of ECHO costs $65.10/ECHO, compared to $14.80/ECHO for TEL. 
Based on a 3-year amortization of fixed cost, costs for ONS exceed those for TEL when the 
transmitting site is more than 3.5 miles from the hub center. 
Conclusion: Low cost tsiemedicine provides a cost-effective alternative to physician travel 
and on site presence, even in e close urban setting. 
1143-166 Smoking Cessation and the Risk of Sudden Cardiac 
Death In Patients With Coronary Heart Disease 
lien Goldenbero, Michael Jonas, Alexander Tennenbaum, Valentine Boyco, Avraham 
Shotan, Solomon Behar, Henrietta Reicher-Reiss, Sheba Medical Center, Tel Hashomer, 
Israel 
Background: Cigarette smoking is a known risk factor for sudden cardiac death (SCD). 
However, the effect of smoking status on SCD risk in patients with established coronary 
heart disease (CHD) remains controversial. 
Methods: We prospectively studied 3122 patients with a previous myocardial infarction 
or stable angina over a mean follow-up period of 7 years - 370 patients were active 
smokers at randomization and throughout the study period; 1821 patients had quit smok- 
ing before or during the follow-up period; 931 patients had never smoked. The rate of 
SCD was determined according to smoking status. 
Results: In current smokers 30 sudden coronary deaths occurred (8.1%), whereas 83 
sudden coronary deaths occurred in patients who had quit smoking (4.6%) and 43 
patients who had never smoked died suddenly (4.6%, p=O.014). In multivariate analyses, 
current smoking was associated with a significant increase in the risk of SCD (relative 
risk- 2.47, 95%CI 1.46-4.19). Patients who had stopped smoking had no significant 
increase in the risk of SCD compared to patients who had never smoked (relative risk - 
1.06, 95%CI 0.70-1.61 Kaplan Meier survival curves comparing active smokers, past 
smokers and never smokers are shown the figure below. 
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Conclusion: In patients with CHD cigarette smoking elevates the risk of SOD, while 
smoking cessation results in a significant reduction in SCD rate. 
JACC March 6, 2002 
1143-167 The Echo Stethoscope: Is It Ready for Prime Time by 
Medical Students? 
Lori B. Croft, Ben Cohen, Thomas Dorantes, Shilpa Hadsh, Matthew Stanizi, Eli Portnoy, 
Anthony Menasia, Eric H. Stem, Martin E. Goldman, Mr. Sinai Medical Center, New York, 
New York. 
Bsekeround: Hand-held inexpensive ultrasound systems have been developed but have 
only been utilized by skilled cardiologists or technologists. The maximum benefit of these 
"echo-stathoscopes" would be to empower all physicians with the skill to perform a "limited" 
bedside echo by incorporating echo into their physical exam as an echostethoscope; not to 
replace a formal echo. Methods: To determine the feasibility of a practical course to train 
medical students to perform echo, four first year medical students underwent a two week 
"hands-on" tutorial to perform and interpret a "limited" echo exam (defined as long, short 
and apical views, but no Doppler) to assess LV and size and function, and the presence of 
significant valvular disease or pericardial effusions. Results: The students acquired echo's 
in the emergency ward (119 pts) and intensive care unit (118 studies). The students' echo 
studies were overread and repeated by an echooardiologist who graded the student's tech- 
nical and interpretive skills. Of the 237 studies, 160 were done on the Cypress ® lap-top 
system (Acuson/Siemans) and 77 on the Sonosite ® hand-held system (Sonosite). The stu- 
dent's echo exam took 8.05 rain (_+ 3.5 mini. The students' limited echo was technically 
diagnostic in 96% and interpreted correctly in 80%. ~oncluelons: Thus, small echo sys- 
tems enable medical students to perform and accurately interpret limited studies following 
a brief training. Implications of this study support the feasibility of formally educating medi- 
cal students to utilize bedside echo-stethoscopes. 
1143-168 Cardiac Valve Calc i f icat ion Is an Important Predictor for  
Mortality in Renal Failure Patients on Dialysis 
Anaela Yee-Mson Wang, Mei WANG, Siu Fai LUI, John E. SANDERSON, Prince of 
Wales Hospital, Chinese University of Hong Kong, Hong Kong, Hong Kong. 
Background. Cardiac valve calcification (VC) is a frequent complication in dialysis patients. 
This study aims to determine the impact of VC on the outcome of these patients. 
Method. Echocardiography was performed in 191 peritoneal dialysis patients to determine 
the presence of calcification of the mitral, aortic valve or both, Patients were followed up 
prospectively for a median duration of 15.4 (range, 2.0-22.9) months. All-cause and cardio- 
vascular mortality were studied in relation to VC. 
Results. Mean age: 55 (12) yrs (M:F=97:94). Mean dialysis duration: 39 (31) months. 51 
patients (33%) had VC. Mean follow-up duration was 15 (4) vs 16 (4) months (VC vs non- 
VC). 40 endpoints (33 deaths and 7 transplants) were observed. 50% deaths were cardio- 
vascular causes. 28% (VC) vs 12% (non-VC) died among which 59% (VC) vs 38% (non- 
VC) group was from cardiovascular causes. Overall 1-year survival was 78% (VC) vs 92% 
(non-VC) (P=0.004). Mortality due to cardiovascular causes was 15% (VC) vs 4% (non- 
VC) (P=0.004; log rank test). VC patients had higher all-cause [Hazard ratio (HR) = 2.62, 
(95% CI: 1.32-5.19); P=0.006] and cardiovascular mortality [HR = 5.71, (95% CI: 2.12- 
15.37); P=0.001] than non-VC patients. Using stepwise Cox regression analysis, VC 
remained significantly & independently associated with an increased all-cause and cardio- 
vascular mortality after adjusting for demographic (age, sex, dialysis duration, diabetes, 
smoking), biochemical (CRP, albumin, calcium x phosphate, parathyroid hormone, choles- 
terol), blood pressure and atherosclerotic diseases (AVD). Presence of both aortic and 
mitral VC had a HR of 5.72 (95% CI: 1.43-22.90) (P=0.014) while those with either mitral or 
aortic VC had a HR of 3.54 (95% CI: 1.19-10.54) (P=0.023) for all-cause mortality than 
those with no VC, Moreover, all-cause and cardiovascular mortality were significantly 
higher among patients with both VC and AVD compared to those having either VC or AVD 
and were in turn higher than those with neither VC nor AVD. 
Conclusions. VC is a powerful predictor for mortality and cardiovascular deaths in dialysis 
patients. Its co-existence with clinical AVD represents more severe atherosclerofic dis- 
eases and predicts a worse outcome. 
1143-169 Cost Comparison of Radiofrequency Ablation and 
Antiarrhythmic Therapy of Atr ia l  F lutter 
Brahmaiee Nallamothu, Frank Pelosi, Jr., Bradley P. Knight, S. Adam Strickberger, Fred 
Morady, Hakan Oral, Universi~ of Michigan, Ann Arbor, Michigan. 
Purpose: Radiofrequency ablation (RFA) is very effective in treatment of atrial flutter (AFI). 
However, RFA is associated with procedural costs and low-incidence of potential complica- 
tions. The purpose of this study was to compare the cost of RFA and antiarrhythmic (AA) 
therapy in patients with AFI. 
Methods: Using a Marker model, the clinical benefits and costs of 2 treatment strategies, 
RFA and chronic AA therapy with a class IC agent, propafenone, were compared in a 
hypothetical cohort of men and women at a mean age of 50. The base-case estimates and 
costs were derived from the literature and 60 consecutive patients who underwent RFA at 
the University of Michigan (mean age= 58 -+ 13). Major assumptions of the model were: 1) 
an annual AFI event rate of 4 episodes per year; 2) a 60% risk reduction with propafenone; 
3) a 10% annual discontinuation rate for prepafenone; 4) an annual pro-arrhythrnia rate of 
0.025% with propafenone; 5) a 90% RFA-success rate for PAF; 6) an RFA-complication 
rate of 1% and a mortality rate of 0.1%; and 7) a 10% annual AFI recurrence rate after RFA, 
Results: Compared to chronic AA, RFA was the dominant strategy in patients with AR, 
reducing lifetime arrhythmia-assooiated costs by $41,000. This result was robust to a wide 
range of potential values for several key model inputs including the frequency of AFI events 
and the efficacy, complication rates, and costs of AA therapy and RFA. For instance, RFA 
remained more effective and less expensive than chronic AA therapy during a sensitivity 
analysis where we assumed that RFA efficacy was lowered to 75%, its complication and 
mortality rates were increased to 3% and 0.3%, respectively, and its costs were doubled. 
Conclusions: RFA for AFI in patients without structural heart disease is associated with a 
substantial decrease in lifetime arrhythmia-associated costs when compared to AA ther- 
apy. 
